Michael Garshick, MD, examines the role of inflammation in coronary disease development, detailing how this risk factor can be detected and treated.

When should a clinician tell a patient they have a gene variant that appeared incidentally but may have ramifications for cardiovascular health?

Surgeons at NYU Langone Health successfully transplanted two genetically engineered pigs hearts into recently deceased humans in June and July.

Hello Heart, a digital therapeutics company that focuses on heart health, has raised $70 million in a Series D funding round.

While 96% of the population is located within 60 minutes of an ED with any acute stroke expertise, many smaller, critical access hospitals in rural regions still are without these lifesaving services.

Machine learning is playing a key role in predicting all major forms of drug cardiotoxicity, potentially helping reduce late-stage clinical trial failures.

Heart attack patients aged 65 and up stay hospitalized longer than those aged 65 or under—yet the seniors ring up significantly smaller bills per stay. The bad news is that the “savings” likely come in the form of fewer percutaneous coronary interventions (PCIs, aka angioplasties) to open blocked heart arteries nonsurgically.

InTouch Health, the leading enterprise telehealth platform, announced today a partnership agreement with Cardiovascular Institute of the South (CIS) to provide remote medical services geared towards emergent and general cardiology expertise in acute settings, adding a fourth service line to the company's physician capacity management offering. CIS will increase breadth and depth of adoption of InTouch Health's services, and extend its cardiology expertise to InTouch Health in two critical ways: (1) addition of cardiologists to InTouch Health's physician capacity management offering, and (2) collaboration on development of workflow solutions to drive best practices and allow for standardized quality of care in telecardiology settings.